HPS-023 - Opportunities for oncology pharmacists in the field of oral cancer therapy

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-023
• By: KUZMANOVIC, Maja (Esop Global, Bosnia and Herzegovina)
• Co-author(s): Dr Maja Kuzmanovic (Esop Global, Zenica, Bosnia and Herzegovina)
  Dr Artur Balogh (Esop Global, Hungary)
  Dr Zsuzsanna Bodor (Esop Global, Hungary)
  Dr Laura Budau (Esop Global, Romania)
  Dr Fabrizio Festinese (Esop Global, Italy)
  Dr Nilgun Kizilmese (Esop Global, Belgium)
  Dr Klaus Meier (Esop Global, Germany)
  Dr Silvia Mira (Esop Global, Portugal)
  Dr Marika Saar (Esop Global, Estonia)
  Dr Jelena Rosentreter (Esop Global, Germany)
  
• Abstract:

  Introduction:
  Until two decades ago the major portion of cancer therapies was based on the parenteral route of administration. Considering the importance of patients’ quality of life, the therapeutic focus shifted to oral administration of oncology drugs as compared to the parenteral route. Oral administration is considered as one of the most..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login